StonvexLoading…
StonvexStonvexStonvexCore line items from COUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $757.50M | $694.70M | $635.80M | $523.76M |
Operating Income | $-77.40M | $-113.20M | $-145.60M | $-177.38M |
Net Income | $-51.00M | $-79.50M | $-116.60M | $-175.36M |
EPS (Diluted) | $-0.31 | $-0.51 | $-0.77 | $-1.21 |
Total Assets | $1.00B | $930.30M | $920.53M | $947.60M |
Total Liabilities | $364.30M | $332.90M | $304.34M | $253.02M |
Cash & Equivalents | $792.60M | $726.10M | $656.30M | $320.82M |
Free Cash Flow OCF − CapEx | $107.20M | $93.80M | $28.60M | $-39.63M |
Shares Outstanding | 167.90M | 160.10M | 155.32M | 147.94M |